"I love Castle Biosciences: Molecular Diagnostics for Cancers"

2022-09-17 13:27:10

Skip to contentPHYSICIAN LOGIN   |   RESEARCHER LOGINCONTACT A REPRESENTATIVEORDER A TESTDecisionDx®-MelanomaLimitations of Traditional Prognostic ApproachesStaging-Only MethodSentinel Lymph Node Biopsy ProcedureDecisionDx-MelanomaOverviewUnderstanding DecisionDx-Melanoma ResultsClinical ValidationClinical Utility StudiesProspective StudiesMeta-Analysis/Systematic Reviews and GuidelinesAnalytic ValidationTest ProcessOrdering and ReportingPatient AccessResourcesMelanoma Expert Video SeriesOn-Demand Educational ProgramsScientific ReferencesAdditional Cutaneous Melanoma TestsDecisionDx®-CMSeqmyPath® Melanoma | DiffDx™-MelanomaOverview of Difficult-to-Diagnose Melanocytic LesionsAmbiguity and DiscordanceWhy GEP?Product OverviewmyPath MelanomaDiffDx-MelanomaClinical EvidencemyPath MelanomaDiffDx-MelanomaTest ProcessOrdering and ReportingPatient AccessScientific ReferencesDecisionDx®-SCCSCC LandscapeHigh-Risk SCCSCC Risk FactorsMetastasis and SurvivalDecisionDx-SCCDecisionDx-SCC OverviewClinical EvidenceClinical BenefitsTest ProcessOrdering and ReportingPatient AccessScientific ReferencesOn-Demand Educational ProgramsDecisionDx®-UMDecisionDx-UMDecisionDx-UM OverviewTechnical SuccessDocumented Clinical UseClinical ValidationProspective Clinical Validation StudiesComparison to Other Prognostic MarkersTest ProcessOrdering and ReportingPatient AccessScientific ReferencesResourcesBiopsy ResourcesClinical Sample RepositoryAdditional Uveal Melanoma TestsDecisionDx®-UMSeqDecisionDx®-PRAMETissueCypher®By DiseaseCutaneous Melanoma (Prognostic)Cutaneous Melanoma (Diagnostic)Cutaneous Squamous Cell CarcinomaUveal MelanomaBarrett’s EsophagusSearch ×DecisionDx®-MelanomaLimitations of Traditional Prognostic ApproachesStaging-Only MethodSentinel Lymph Node Biopsy ProcedureDecisionDx-MelanomaOverviewUnderstanding DecisionDx-Melanoma ResultsClinical ValidationClinical Utility StudiesProspective StudiesMeta-Analysis/Systematic Reviews and GuidelinesAnalytic ValidationTest ProcessOrdering and ReportingPatient AccessResourcesMelanoma Expert Video SeriesOn-Demand Educational ProgramsScientific ReferencesAdditional Cutaneous Melanoma TestsDecisionDx®-CMSeqmyPath® Melanoma | DiffDx™-MelanomaOverview of Difficult-to-Diagnose Melanocytic LesionsAmbiguity and DiscordanceWhy GEP?Product OverviewmyPath MelanomaDiffDx-MelanomaClinical EvidencemyPath MelanomaDiffDx-MelanomaTest ProcessOrdering and ReportingPatient AccessScientific ReferencesDecisionDx®-SCCSCC LandscapeHigh-Risk SCCSCC Risk FactorsMetastasis and SurvivalDecisionDx-SCCDecisionDx-SCC OverviewClinical EvidenceClinical BenefitsTest ProcessOrdering and ReportingPatient AccessScientific ReferencesOn-Demand Educational ProgramsDecisionDx®-UMDecisionDx-UMDecisionDx-UM OverviewTechnical SuccessDocumented Clinical UseClinical ValidationProspective Clinical Validation StudiesComparison to Other Prognostic MarkersTest ProcessOrdering and ReportingPatient AccessScientific ReferencesResourcesBiopsy ResourcesClinical Sample RepositoryAdditional Uveal Melanoma TestsDecisionDx®-UMSeqDecisionDx®-PRAMETissueCypher®By DiseaseCutaneous Melanoma (Prognostic)Cutaneous Melanoma (Diagnostic)Cutaneous Squamous Cell CarcinomaUveal MelanomaBarrett’s EsophagusSearch Transforming Patient ManagementActionable Information Addressing Key Questions in Disease States With High Unmet Clinical Needs Skin Cancer Connect NewsletterView Edition CUTANEOUS MELANOMA PROGNOSTICPredicting Individual Risk of Recurrence or Metastasis in Stage I, II and III Melanoma DIAGNOSTICHighly Accurate and Objective Tests Characterizing Difficult-to-Diagnose Melanocytic Lesions Healthcare ProfessionalsPatients & CaregiversHealthcare ProfessionalsPatients and Caregivers SQUAMOUS CELLCARCINOMA PROGNOSTICBetter Identifies Risk of Metastasis in Patients With One or More Risk FactorsHealthcare ProfessionalsPatients & Caregivers UVEALMELANOMA PROGNOSTICThe Standard of Care for Evaluating Metastatic Risk in Uveal MelanomaHealthcare ProfessionalsPatients & Caregivers BARRETT'S ESOPHAGUS PROGNOSTICPredicting Individual Risk of Progression to Esophageal Cancer in Barrett’s EsophagusHealthcare Professionals TESTS BY DISEASECutaneous Melanoma (Prognostic)Cutaneous Melanoma (Diagnostic)Cutaneous Squamous Cell CarcinomaUveal MelanomaBarrett’s Esophagus NEWS & EVENTS CASTLE BIOSCIENCESAbout UsHistoryExecutive ManagementBoard of DirectorsLicensesCareersContact UsCustomer Service: 866-788-9007Privacy Policy | Terms of Use©2022 Castle Test Info All Rights Reserved.This site uses cookies to offer you a better browsing experience. Read our Privacy Policy.We use cookies and share data with services that improve your experience on this site. Read our Privacy Policy.Opt-OutAcceptDeclineCloseCookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.Always ActiveNecessaryNecessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.MarketingMarketingMarketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.AnalyticsAnalyticsAnalytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.PreferencesPreferencesPreference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.UnclassifiedUnclassifiedUnclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.Save And AcceptCookie SettingsDo you really wish to opt-out?CloseCancelConfirm.gdpr_messagebar_detail .category-group .category-item .description-container .group-toggle .checkbox input:checked + label:after,.gdpr_messagebar_detail.layout-classic .category-group .toggle-group .checkbox input:checked + label:after {background: #66cc66 !important;}.gdpr_messagebar_detail .gdprmodal-dialog .gdprmodal-header .close, #gdpr-ccpa-gdprmodal .gdprmodal-dialog .gdprmodal-body .close {color: #66cc66 !important;}Scroll to Top